Ophthalmic medical technology company Glaukos Corporation recently reported a new study that showed a consistent cohort of 107 open-angle glaucoma (OAG) eyes receiving the company's iStent® Trabecular Micro-Bypass Stent in combination with cataract surgery achieved a 22 percent reduction in mean intraocular pressure (IOP) to 15.17 mm Hg, and a 56 percent reduction in mean ocular hypotension medications to 0.61 two years following surgery.
The study of consecutive case studies reportedly included 350 eyes that underwent iStent implantation with concomitant cataract surgery between October 2012 and December 2015. The study was recently published in the journal Clinical Ophthalmology.
Image courtesy Glaukos Corporation
Click here to read the full press release.
Source: Glaukos Corporation